Newcastle Clinical Trials Unit

Haplo

Evaluation of efficacy, outcomes and safety of CD45RO+ memory T cell add-back following haematopoietic cell transplantation in paediatric patients with primary immunodeficiency disorder.

  • Study stage: Set-up
  • Sponsor: Newcastle upon Tyne Hospital
  • Funder: NIHR EME
  • Therapeutic area: Blood

Type of study: CTIMP